NYU Melanoma Biomarker Program
NYU Melanoma SPORE
['FUNDING_OTHER'] · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · NIH-11361723
Personalized blood and tumor markers to help doctors choose the safest and most effective immunotherapy for people with melanoma after surgery.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEW YORK UNIVERSITY SCHOOL OF MEDICINE (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11361723 on ClinicalTrials.gov |
What this research studies
If I have melanoma and receive immunotherapy after surgery, the team will collect my blood and tumor samples and track my treatment results and side effects. Researchers will search for biological signs that predict who will benefit and who may develop serious toxicity. They will develop lab tests for those signs and check them in larger patient groups to make sure the tests work reliably. The goal is to use these markers to guide treatment choices and reduce harmful side effects in everyday care.
Who could benefit from this research
Good fit: Ideal candidates are people with melanoma who are receiving or may receive adjuvant immune checkpoint inhibitor therapy and who can provide blood or tumor samples.
Not a fit: People without melanoma or those not receiving adjuvant immunotherapy are unlikely to benefit directly from participating.
Why it matters
Potential benefit: Could allow more personalized selection of adjuvant immunotherapy, improving benefit and reducing toxic side effects for melanoma patients.
How similar studies have performed: Some studies have found candidate biomarkers for immunotherapy response and toxicity, but few tests are validated for routine clinical use, so this program builds on promising but still-developing evidence.
Where this research is happening
NEW YORK, UNITED STATES
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: OSMAN, IMAN — NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- Study coordinator: OSMAN, IMAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.